GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Skinvisible Inc (OTCPK:SKVI) » Definitions » Cash And Cash Equivalents

Skinvisible (Skinvisible) Cash And Cash Equivalents : $0.01 Mil (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Skinvisible Cash And Cash Equivalents?

Skinvisible's quarterly cash and cash equivalents stayed the same from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($0.01 Mil).

Skinvisible's annual cash and cash equivalents increased from Dec. 2021 ($0.07 Mil) to Dec. 2022 ($0.08 Mil) but then declined from Dec. 2022 ($0.08 Mil) to Dec. 2023 ($0.00 Mil).

Skinvisible Cash And Cash Equivalents Historical Data

The historical data trend for Skinvisible's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skinvisible Cash And Cash Equivalents Chart

Skinvisible Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.04 0.07 0.08 -

Skinvisible Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - - - 0.01

Skinvisible Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Skinvisible  (OTCPK:SKVI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Skinvisible Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Skinvisible's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Skinvisible (Skinvisible) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Skinvisible Inc (OTCPK:SKVI) » Definitions » Cash And Cash Equivalents
Comparable Companies
RCKY SHOO DBI MCRAA VRA CROX WEYS DECK BIRK ONON PG XPAR:OR LSE:ULVR CL BOM:500696 EL KMB LSE:RKT KVUE XTER:BEI
Traded in Other Exchanges
N/A
Address
6320 South Sandhill Road, Suite 10, Las Vegas, NV, USA, 89120
Website
https://www.skinvisible.com
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active.
Executives
St James David M director 3395 S. JONES BLVD., #169, LAS VEGAS NV 89146
Doreen Mcmorran 10 percent owner 6320 S. SANDHILL RD UNIT 10, LAS VEGAS NV 89120
Brian Piwek director 9014 GLENEAGLE DRIVE, BLAINE WA 98230
E Greg Mccartney director #307-15338 18TH AVENUE, SURREY BC A1 V4A 1W8
Jost Steinbruchel director 7, RUE DES BATTOIRS, POBOX #214, 1211 GENEVA 4 V8 000000
Robert F Lutz director, 10 percent owner
Terry Howlett director, 10 percent owner, officer: President & Chief Exec.Officer 6320 S. SANDHILL ROAD, SUITE #10, LAS VEGAS NV 89120
Skinvisible Inc director, 10 percent owner, officer: President 6320 S SANDHILL ROAD, SUITE 10, LAS VEGAS NV 89120
Lutz Family Trust 10 percent owner 8322 WEST TONTO LANE, PEORIA AZ 85382